Country Profile

Cuba

Cuba is an emerging destination for Indian pharmaceutical exports — $4.19M in FY 2025–26. Medicines accounts for 61% of shipments, with vaccines contributing $1.43M.

🇨🇺 $4.19M · 0.3× growth since FY2015
Single-source profile. All data from DGCIS India export records (fiscal year, April–March).
$4.19M
Exports FY2025–26 DGCIS
0.3×
Growth FY2015→2026
61%
Medicines Share
4
Product Categories Supplied
12
Years of Trade Data
Cuba is an emerging destination for Indian pharmaceutical exports — $4.19M in FY 2025–26. Medicines accounts for 61% of shipments, with vaccines contributing $1.43M.
Export Trend DGCIS FY
Category Mix — FY 2025–26 DGCIS
Medicines $2.55M (60.8%) Vaccines $1.43M (34.1%) Medicine Ingredients $175K (4.2%) Surgical & Hospital Supplies $38K (0.9%)
Top 10 Products — FY 2025–26 DGCIS
Indian Pharma Investment Source: RBI ODI Data

No recorded pharmaceutical sector investment transactions from Indian companies to Cuba in the RBI overseas direct investment dataset (2011–2026).